Article info
PDFCorrespondence
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares
- Correspondence to Dr. Arnaud M Didierlaurent, GSK, Wavre 1300, Belgium; arnaud.x.didierlaurent{at}gsk.com
Citation
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares
Publication history
- Received November 13, 2019
- Accepted November 17, 2019
- First published December 2, 2019.
Online issue publication
November 12, 2021
Article Versions
- Previous version (2 December 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.